PLUSMEDIUM SIGNALFINANCIAL10-K

ePlus demonstrated solid cash generation with substantially higher cash reserves, though operating income declined modestly amid mixed operational metrics.

The company's cash position strengthened meaningfully to $389.4M, indicating robust liquidity and financial flexibility for growth investments or shareholder returns. However, the decline in operating income alongside higher liabilities suggests some operational headwinds that warrant monitoring, particularly given the company's exposure to cyclical technology spending patterns.

Comparing 2025-05-22 vs 2024-05-23View on EDGAR →
FINANCIAL ANALYSIS

ePlus showed a mixed financial picture with cash reserves growing substantially to $389.4M and operating cash flow advancing 21.6% to $302.1M, demonstrating strong cash generation capabilities. However, operating income declined 10.6% to $141.4M while total liabilities increased 20.7%, suggesting some margin pressure and increased financial obligations. The reduction in both accounts receivable and inventory points to improved working capital management, though this coincided with the operating income decline.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
+53.9%
$253.0M$389.4M

Cash position surged 53.9% — strong cash generation or capital raise providing significant financial cushion.

Operating Cash Flow
Cash Flow
+21.6%
$248.4M$302.1M

Operating cash flow grew 21.6% — strong conversion of earnings to cash, healthy business fundamentals.

Current Liabilities
Balance Sheet
+21.4%
$657.0M$797.9M

Current liabilities rose 21.4% — increased short-term obligations, watch current ratio.

Total Liabilities
Balance Sheet
+20.7%
$751.7M$907.2M

Liabilities increased 20.7% — monitor debt-to-equity ratio and interest coverage.

Accounts Receivable
Balance Sheet
-19.8%
$644.6M$517.1M

Receivables declined — improved collection efficiency or conservative revenue recognition.

Total Assets
Balance Sheet
+14%
$1.7B$1.9B

Asset base grew 14% — expansion through organic growth, acquisitions, or capital deployment.

Inventory
Balance Sheet
-13.8%
$139.7M$120.4M

Inventory reduced 13.8% — lean inventory management or demand outpacing supply.

Operating Income
P&L
-10.6%
$158.3M$141.4M

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

LANGUAGE CHANGES
NEW — 2025-05-22
PRIOR — 2024-05-23
ADDED
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.
See definition of large accelerated filer , accelerated filer , smaller reporting company , and emerging growth company in Rule 12b-2 of the Exchange Act.
The outstanding number of shares of common stock of e Plus as of May 20, 2025, was 26,526,783 .
BUSINESS OUR BUSINESS e Plus inc., sometimes referred to in this Annual Report on Form 10-K as we, our, us, ourselves, or e Plus, has been delivering solutions for our customers since 1990.
OUR CUSTOMERS We serve 4,600 customers that are primarily middle market to large enterprises and state and local government institutions, including state and local education ( SLED ) institutions, across diverse customer end markets.
+7 more — sign up free →
REMOVED
The outstanding number of shares of common stock of e Plus as of May 20, 2024, was 26,951,935 .
BUSINESS OUR BUSINESS e Plus inc., sometimes referred to in this Annual Report on Form 10-K as we, our, us, ourselves, or e Plus.
, has been delivering solutions for our customers since 1990.
OUR CUSTOMERS We focus primarily on diverse end-markets for middle market to large enterprises.
We serve customers in markets including telecom, media and entertainment, technology, state and local government and educational institutions ( SLED ), healthcare, and financial services.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →